Hexaminolevulinate Hydrochloride

CHEMBL1201785 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
251.8 g/mol
LogP
Phase
4

This is the hydrochloride salt form of hexaminolevulinate, a photosensitizing diagnostic agent used to enhance the detection of bladder cancer during fluorescence cystoscopy. Cancer cells absorb and metabolize it more actively than normal cells, making them fluoresce under special blue light. The hydrochloride salt form ensures solubility for bladder instillation.

分子量

251.7500 g/mol

TPSA

69.40 Ų

治療領域

作用機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCCCOC(=O)CCC(=O)CN.Cl

InChI

InChI=1S/C11H21NO3.ClH/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12;/h2-9,12H2,1H3;1H

Molecular Formula

C11H22ClNO3

HBD / HBA

2 / 4

回転可能結合数

10

重原子数

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This is the hydrochloride salt form of hexaminolevulinate, a photosensitizing diagnostic agent used to enhance the detection of bladder cancer during fluorescence cystoscopy. Cancer cells absorb and metabolize it more actively than normal cells, making them fluoresce under special blue light. The hydrochloride salt form ensures solubility for bladder instillation.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Hexaminolevulinate Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201785. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6433082. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.